Number of Portfolio Companies 1
Number of Current Board & Advisor Roles 4
  • Primary Job Title Board of Directors
  • Primary Organization 
    Bloxr
  • Investor Type  Investment Partner, Individual/Angel

Jim Dreyfous co-founded Pelion Venture Partners in 1986 and has been a managing director since its formation. After more than 25 years, his passion for building companies continues. Dreyfous personifies the Pelion culture and approach—he is active with business founders and directors, experienced in building and developing management teams, and

adept at accessing strategic relationships to help companies attract management expertise and capital at every stage of a company's growth.

Dreyfous spent his early career in commercial banking, oil and gas production and distribution, private investments and small business management.

He serves on the Utah Science, Technology and Research (USTAR) Governing Authority Board, where he was appointed by the governor and state legislature, and a number of portfolio company boards including Adapx, BloXR, Skylight and Venafi.

Dreyfous has a BA in economics from Middlebury College.

Number of Investments 2
Jim Dreyfous has made 2 investments. Their latest investment was Seed Round - WISHLYapp on Nov 15, 2021, when WISHLYapp raised
$800K
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
Nov 15, 2021
WISHLYapp
Seed Round - WISHLYapp
$800K
Jun 1, 2020
WISHLYapp
Pre Seed Round - WISHLYapp
$400K
Number of Past Jobs 1
Jim Dreyfous has had 1 past job as the Founding Partner at Pelion Venture Partners.
Organization Name  
Title At Company  
Start Date  
End Date  
Pelion Venture Partners
Founding Partner1986
Number of Current Board & Advisor Roles 4
Number of Past Board & Advisor Roles 1
Jim Dreyfous holds 4 board and advisor roles including Board of Directors at AngioScore, Board Member at Skylight Healthcare Systems, and Board of Directors at Adapx.
Organization Name  
Title At Company  
Start Date  
End Date  
Venafi
Board of DirectorsMar 1, 2014
Funding RoundNov 15, 2021
Funding RoundJun 1, 2020